The advanced wound care is one of the emerging sector that offers solutions and devices to manage chronic and acute wounds. Advanced wound therapy devices can treat wounds occured from venous ailment, weight ulcers, diabetes, and others. The developing geriatric people which is powerless to diabetes and peripheral vascular ailment can open up open doors for the market. This can be credited to matured skin hindering recuperating rates. Likewise, improvement of cutting edge gadgets which can facilitate the recuperating procedure in chronic wounds is probably going to support request in the advanced wound therapy devices market. Be that as it may, surprising expenses of these gadgets can compromise its development. The global advanced wound therapy devices market is expected to reach the valuation of USD 2,804.53 million by the year 2023, by growing at a CAGR of 6.70% CAGR during the forecast period (2018-2023).
The global advanced wound therapy devices market is bifurcated on the basis of its end-user and type. Based on its type, the market is segmented into hyperbaric oxygen equipment, negative pressure wound therapy systems, electric stimulation devices, pressure relief devices, and others. On the basis of its end-users, the market is bifurcated into hospitals & clinics, home care settings, and others.
Geographically, the global advanced wound therapy devices market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.
KCI Licensing, Inc. (U.S.), Lohmann & Rauscher GmbH & Co. KG (Germany), DeRoyal Industries, Inc. (U.S.), Medela AG (Switzerland), Perry Baromedical (U.S.), Triage Meditech Pvt. Ltd. (India), and Sechrist (U.S.), Smith & Nephew plc (U.K.), M?lnlycke Health Care AB (Sweden), B. Braun Melsungen AG (Germany), ConvaTec Inc. (U.K.), Cardinal Health (U.S.), among others are some of the major players in the global advanced wound therapy devices market.